Juntendo University · Graduate School of Medicine / Faculty of Medicine

Research keywordsprogressive supranuclear palsy・Parkinson disease・neuronal intranuclear inclusion disease・MORC2 neuropathy・amyotrophic lateral sclerosis・motor neuron disease・QSM imaging・placebo effect

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Haji S, Sako W, Hanada K, Matsubara T, Osaki Y, Matsumoto Y, Harada M, Izumi Y. Magnetic Susceptibility and Area in the Subthalamic Nucleus Measured by QSM for Diagnosis of Progressive Supranuclear Palsy. Mov Disord Clin Pract. 2025 May2025
• Osaki Y, Nodera H, Sato R, Haji S, Fujita K, Miyamoto R, Muto K, Yamazaki H, Morino H, Kanda T, Murayama S, Kaji R, Izumi Y. Peripheral nerve excitability abnormalities in Neuronal Intranuclear Inclusion Disease: Assessment with histopathological analysis. Clin Neurophysiol. 2025 Feb;170:156-167. doi:2025
• Nakamura K, Fujita K, Suzuki M, Kunugi A, Hirozane Y, Kunikata T, Takahashi B, Narazaki G, Kondo H, Haji S, Hirai K, Izumi Y. Neuroinflammation and glycosylation-related cerebrospinal fluid proteins for predicting functional decline in amyotrophic lateral sclerosis: a proteomic study. Front Neurol. 2024 Nov 18;15:1418320. doi: 10.3389/fneur.2024.1418320. PMID: 39624674; PMCID: PMC11608993.2024
• Hanada K, Osaki Y, Miyamoto R, Muto K, Haji S, Nazere K, Kuwano Y, Morino H, Azuma Y, Miyatake S, Matsumoto N, Izumi Y. Intermediate phenotype between CMT2Z and DIGFAN associated with a novel MORC2 variant: a case report. Hum Genome Var. 2024 Aug 15;11(1):29. doi: 10.1038/s41439-024-00287-8. PMID: 39143067; PMCID: PMC11324651.2024

• Official profile